Ukudibanisa nezinye izinto ezininzi, uVictoza unokunceda abo abane-PCOS
I-Polycystic i-ovary syndrome (i-PCOS) yinto eqhelekileyo kubasetyhini beminyaka yobudala kwaye ingabangela ukungabikho kwengxaki kunye neengxaki zokuxilonga. Phantse ama-50 ukuya kuma-70 ekhulwini kwabasetyhini abane-PCOS bafumana ukunganyangeki kwe-insulin, okukholelwa ukuba yimbangela ebangela imeko. Ubuncinane isiqingatha sabasetyhini abane-PCOS banamandla kakhulu okanye baninzi. Ngelixa i-PCOS ingenza kube nzima ukunciphisa ubunzima, uphando lubonise ukuba ukulahleka kwesisindo se-5 ukuya kwi-10 ekhulwini lesisindo somzimba kunokuphucula imiba yezinto eziphathekayo kunye nokuzala.
Ukuba unayo i-PCOS kwaye ufumanisa nzima kunciphisa umzimba, amayeza anokunceda.
I-Metformin , isifo sikashukela, isilwanyana esidumile esasetyenziswa phakathi kwamagqirha ukunyanga kwe-insulin kwi-PCOS, kodwa ayiphumeleli ekulahlekeni komzimba. Uphando lubonisa ukuba omnye unyango lwesifo sikashukela, uVictoza, unokunceda abo abane-PCOS banciphise umzimba kwaye baphucule iimpawu zokumaketha. I-Victoza, kunye ne-metformin kunye neenguqu zokuphila, ingaba yindlela ephumelelayo yokulahlekelwa isisindo xa unayo i-PCOS kwaye uhluleka ukunciphisa ubunzima naphezu kweenguqu zokutya, i-insulin-yokunciphisa izondlo, ukusetyenziswa kwempahla kunye ne-metformin.
Yintoni iVictoza?
I-Victoza (i-Liraglutide) yipilisi ejoyiweyo isakhiwo esifanayo kwi-glucagon-njenge-peptide-1 (GLP-1). I-GLP-1 yi-hormone yamathumbu ephakamisa i-glucose-evuselelwe i-insulin secretion, inqanda ukukhutshwa kwe-glucagon, ukulibaziseka isisu esiswini kunye nokunciphisa ukutya nokutya. I-Victoza yavunywa ngo-2010, kwabo bahlobo lwesifo sikashukela , kodwa sinokukunceda nabo abane-PCOS.
I-Victoza iboniswe ngokuthe ngqo kwi-HbA1c kunye nesisindo somzimba. I-Victoza nayo inegalelo elikhulu ekulahlekeni kwesisindo kunye nomngcipheko omncinci we-diabetes kwisandulela sesifo sikasifo sikasifo sikasifo sikasifo sikashukela, kangangokuthi iKomiti Yokucebisa i-Endocrinologic ne-Metabolic Drugs Committee ivotelwe ukuba iVicza ivunyelwe ukuba ilawulwe ukulawula ubunzima.
Iziphumo ezixhamlayo kwixinzelelo legazi kunye namazinga e-cholesterol aboniswe kubantu abathatha i-Victoza.
UVictoza usebenza ngokunciphisa ukukhutshwa kokutya esiswini sakho. Ukuba ne-PCOS inokuphazamisa amanqanaba akho ehomoni ezilawula ukutya. Ukuthatha iVictoza kunokukunceda uzive ugcwele ngokukhawuleza, kwaye unamava okuncinci. Ngenxa yoko, ngelixa uthatha iVictoza, uya kudla ukutya okuncinci kwaye ngoko unciphise umzimba.
Oko Uphando lubonisa
Kwisifundo sokuqwalasela, abafazi abane-PCOS abathabatha i-Victoza kunye ne-Metformin kwiinyanga ezili-7 babonisa ukulahleka kwesisindo semali ezili-20. Amashumi amabini anesibini amabhinqa alahlekelwa ngaphezu kwama-5 ekhulwini kunye nama-33 ekhulwini alahlekelwa ngaphezu kweepesenti ezili-10 zobunzima bawo obunzima. Ukongeza kokuthatha i-Victoza, abafazi ekufundeni badla ukutya okuphantsi kwe-glycemic ngaphandle kwesithintelo sekharori, bafumana isikhokelo ngumbutho wesondlo , kwaye baqhuba imizuzu engama-45 yokuzivocavoca ngokulinganayo kathathu ngeveki nganye.
Uphando oluncinci luphande umphumo we-Victoza kunye neMetformin kwizigulane ze-PCOS. Kubonisa ukulahlekelwa ngokunyaniseka okukhulu kunye neyeza ezidibeneyo kunye ne-metformin yedwa.
Yintoni Okumele Uyazi Ngokuthatha I-Victoza
Ukuba unayo i-PCOS kwaye awukwazi ukulahlekelwa isisindo nangona ulandela ukutya okunempilo nokuphila , ukongeza i-Victoza kwi-regimen yakho inokukunceda.
Ukuba unomdla wokuzama uVictoza, thetha ugqirha wakho. I-Victoza ingabangela iziphumo zesisu esiswini xa uqala imichiza, kubandakanywa isicathulo, ukuhlanza, isifo sohudo, ukuzitywa, kunye nesisu esiswini. Ezi ziqhelo zihlala zihamba emva kokuthatha iilisi ixesha elide. Kwizilwanyana zezilwanyana, uVictoza wayedibaniswe nezicubu ze-thyroid. Akungaziwa ukuba i-Victoza ibangelwa iisifo ze-thyroid okanye umdlavuza kubantu. Ngelixa likhethiweyo lonyango oluthembisayo, kukho iimfuno ezininzi zokuhlola ukusetyenziswa kwexesha elide likaVictoza.
> Imithombo:
> Bode B. Inkcazo ye-Pharmacokinetics, i-Efficacy, kunye noKhuseleko lweLiraglutide. Isifo sikashukela Res Clin Pract (2012) 97: 27-4210.1016.
> I-Rasmussen CB, i-Lindenberg S. Umphumo weLiraglutide kwi-Lossight Weight in Women with Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2014 uAgasti 27; 5: 140.
> Jensterle Sever M, Kocjan T, Pfeifer M, Kravos NA, Janez A. Ukwelapha okufutshane kunye ne-Liraglutide kunye ne-Metformin kubangela ukulahlekelwa kobutyebi obunzima kwiiNtshontsho eziPhezulu ezinePycycystic Ovary Syndrome kunye neMpendulo engapheliyo kwi-Metformin. Eur J Endocrinol. 2014 Mar; 170 (3): 451-9.
> Moran LJ, Noakes M, Clifton PM, et al. I-Postprandial Ghrelin, i-Cholecystokinin, i-Peptide YY, ne-Appetite Ngaphambi nangemva kokunyuka kobunzima kwi-Womenight Overweight ne-Without Polycystic Ovary Syndrome. Am J Clin Nutrition . 2007; 86 (6): 1603-1610.
> Vilsboll T, Christensen M, Junker AE, Knop FK, Gluud LL. Iimpembelelo ze-Glucagon-njengePeptide-1 I-Agonists kwi-Weight Loss: Ukuphononongwa koHlolo kunye ne-Meta-Uhlalutyo lwezilingo ezilawulwe ngokungaqhelekanga. I-BMJ (2012): 344.